NCT00001381已完成1 期
A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 18
- 试验地点
- 2
研究概览
简要总结
Patients with superficial transitional cell carcinoma of the bladder will be treated with intravesical suramin in a phase I dose escalating study. The toxicity of suramin administered in this fashion will be evaluated.
详细描述
Patients with superficial transitional cell carcinoma of the bladder will be treated with intravesical suramin in a phase I dose escalating study. The toxicity of suramin administered in this fashion will be evaluated.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
Suramin in Treating Patients With Recurrent Bladder CancerBladder CancerNCT00006476Cancer Research UK15
招募中
1 期
A Phase I Intravesical PPM Therapy for NMIBCNon-muscle-invasive Bladder CancerNCT05519241VA Office of Research and Development29
Unknown
1 期
Selinexor Combined With Standard Chemoradiation as Neoadjuvant Treatment in Locally Advanced Rectal CancerRectal NeoplasmsNCT02137356Sheba Medical Center28
已完成
2 期
Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer TreatmentBladder CancerNCT01489813Emory University36
终止
2 期
A Phase II Randomized Trial of Immunotherapy Plus Radiotherapy in Metastatic Genitourinary CancersMetastatic Renal Cell CarcinomaMetastatic Urothelial CarcinomaNCT03115801Weill Medical College of Cornell University6